E

Editas Medicine

CRISPR-based gene editing therapeutics developer

Scientist 1, Computational Biology

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
ContractCambridge, MA, USA$64 - $69 /hrIn-person

About the Job

Requirements

  • The Scientist I level requires a PhD in bioinformatics, computer science, biology, or a relevant computational discipline.
  • Demonstrated hands-on experience with next-generation sequencing (NGS) data analysis, such as targeted amplicon sequencing, whole genome sequencing, or RNA sequencing.
  • Demonstrated programming and developer skills, such as Linux/Unix, Python, R, and Git, with experience in cloud computing such as AWS, Docker, Snakemake, and agentic AI tools such as Claude Code.
  • Familiarity with bioinformatics packages and algorithms related to NGS data analysis, such as Bowtie2, STAR, Minimap2, Samtools, or Bioconductor.
  • Strong documentation and organizational skills, including experience with electronic laboratory notebooks such as Benchling.
  • Ability to work effectively in a collaborative, multidisciplinary, and timeline-driven environment.
  • Excellent written and verbal communication skills.

Responsibilities

  • Perform sophisticated computational analyses of NGS data using critical thinking, published findings, field best practices, and data science visualizations.
  • Partner with computational biology, informatics, and analytical development teams to develop and maintain reproducible, usable, version-controlled, and robust computational biology pipelines and workflows.
  • Define, troubleshoot, and optimize analysis specifications for novel NGS analyses to establish assay acceptance criteria.
  • Maintain well-documented workflows, author study reports, and provide technical documentation supporting research, analytical development, and regulatory activities.
  • Present scientific findings to broad audiences, including senior leadership, to inform decision-making for therapeutic programs.

Desired Qualifications

  • Experience analyzing NGS data from CRISPR or other gene-editing modalities, including characterization of on-target editing, off-target editing, structural variants, or other editing outcomes.
  • Experience analyzing data from Oxford Nanopore sequencing.
  • Experience analyzing guide RNA sequencing data from Illumina or Oxford Nanopore sequencing platforms.
  • Experience analyzing data from high-throughput targeted sequencing and multiplexed amplicon assays.
  • Experience supporting assay development in a biotechnology or pharmaceutical environment.

About the Company

Editas Medicine

CRISPR-based gene editing therapeutics developer

Editas Medicine develops therapies using CRISPR gene-editing to treat serious diseases. The company advances a pipeline of genomic medicines by discovering, developing, manufacturing, and aiming to commercialize these gene-editing treatments. CRISPR allows scientists to modify DNA in cells to correct genetic defects, and Editas combines this approach with clinical development to bring potential medicines to patients. Unlike firms that focus on other biotechnologies, Editas emphasizes a full drug-development cycle centered on CRISPR-based genomic medicines and partnerships to expand its reach. The company’s goal is to deliver durable, transformative treatments that improve patient outcomes worldwide by moving candidates from discovery through trials to potential approval and commercialization.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Editas Medicine

See more jobs